The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost of consent document (CD) translation is a potential barrier to consenting limited English-proficient participants (LEPPs) in non-industry–sponsored studies (NISS).
 
Maria A Velez
No Relationships to Disclose
 
Maggie Lindenbaum
No Relationships to Disclose
 
Manavi Hegde
No Relationships to Disclose
 
Jenny Brook
No Relationships to Disclose
 
Andrea Nañez
No Relationships to Disclose
 
Jackson P Lind-Lebuffe
No Relationships to Disclose
 
Paige M Brodrick
No Relationships to Disclose
 
Yazeed Radwan
No Relationships to Disclose
 
Maria Jose Fernandez Turizo
No Relationships to Disclose
 
Nawal M Yessuf
No Relationships to Disclose
 
Hsin Hsiang Clarence Tsai
No Relationships to Disclose
 
Amy Lauren Cummings
Consulting or Advisory Role - OncLive/MJH Life Sciences; Tempus
Research Funding - Amgen Foundation; Genentech (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for bioinformatics approach to identification of motif neoepitopes
 
Aaron E. Lisberg
Employment - Boston Scientific (I)
Stock and Other Ownership Interests - Boston Scientific (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Leica Biosystems; Lilly; MorphoSys; Novartis; Novocure; Oncocyte; Pfizer; Sanofi/Regeneron
Research Funding - AstraZeneca; Calithera Biosciences; Daiichi Sankyo; Dracen; WindMIL
 
David Elashoff
No Relationships to Disclose
 
Michael Teitell
No Relationships to Disclose
 
Beth A Glenn
No Relationships to Disclose
 
Edward B. Garon
Consulting or Advisory Role - ABL Bio; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Merck; Natera; Novartis; Personalis; Sanofi/Regeneron; Shionogi; Xilio Therapeutics
Research Funding - ABL Bio (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); EMD Serono (Inst); Genentech (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neon Therapeutics (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Diagnosistic and therapeutic use of "Motif Neoepitopes" as defined by Cummings et al in Nature Cancer. (Inst)